Jodi Devlin
Chief of Clinical Operations at TriSalus Life Sciences, Inc. (TLSI) since August 2023
Jodi Devlin has filed 8 insider reports with the SEC since September 2023, as chief of Clinical Operations at TriSalus Life Sciences, Inc. (TLSI). In the last 12 months Jodi Devlin sold $13.2K of stock on the open market. In the latest filing, on March 20, 2026, Jodi Devlin sold 3,207 shares of TriSalus Life Sciences, Inc. (TLSI) for $13.2K at an average of $4.11.
- Filings
- 8
- Companies
- 1
- Bought on market
- None
- Sold on market
- $37.8K
Companies where Jodi Devlin is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief of Clinical Operationssince August 2023 | 97,364 | $37.8K | $2.52 | Mar 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 16, 2026-$13.2KTLSISEC Form 4 filed by Devlin JodiForm 4Open-market sale
- Nov 24, 2025TLSIChief of Clinical Operations Devlin Jodi was granted 50,000 shares, increasing direct ownership by 99% to 100,571 unitsForm 4Grant or award
- May 19, 2025-$24.7KTLSIChief of Clinical Operations Devlin Jodi was granted 24,131 shares and sold $24,678 worth of shares (4,764 units at $5.18), increasing direct ownership by 58% to 52,764 unitsForm 4Grant or awardOpen-market sale
- Feb 18, 2025TLSIChief of Clinical Operations Devlin Jodi was granted 5,272 shares, increasing direct ownership by 19% to 33,397 unitsForm 4Grant or award
- Jan 27, 2025TLSIChief of COMMERC. OPERATIONS Devlin Jodi was granted 10,625 shares, increasing direct ownership by 61% to 28,125 unitsForm 4Grant or award
- Feb 12, 2024TLSIDevlin Jodi was granted 17,500 sharesForm 4Grant or award
- Aug 30, 2023TLSISEC Form 4 filed by Devlin JodiForm 4Grant or award
- Aug 28, 2023TLSIJodi Devlin became an insiderForm 3New insider
Compare Jodi Devlin with
- Jodi Devlin vs David Patience1 shared
- Jodi Devlin vs Mary T Szela1 shared
- Jodi Devlin vs Richard Marshak1 shared
- Jodi Devlin vs Richard Henry Marshall1 shared
- Jodi Devlin vs Mats Wahlstrom1 shared
- Jodi Devlin vs Michael P Stansky1 shared
Other insiders at the same companies
- David PatienceTLSI
- Mary T SzelaTLSI
- Richard MarshakTLSI
- Richard Henry MarshallTLSI
- Mats WahlstromTLSI
- Michael P StanskyTLSI
- Gary B. GordonTLSI
- Kerry R HicksTLSI
- David J MatlinTLSI
- William ValleTLSI
- Equity AB FrankeniusTLSI
- Bryan F. CoxTLSI
- Jennifer StevensTLSI
- Arjun JJ DesaiTLSI
- Sean MurphyTLSI
- James Emmett YoungTLSI
Questions about Jodi Devlin
- What is Jodi Devlin's role at TriSalus Life Sciences, Inc.?
- Jodi Devlin reports to the SEC as chief of Clinical Operations at TriSalus Life Sciences, Inc. (TLSI), according to the latest filing on March 20, 2026.
- How many shares does Jodi Devlin own?
- After the latest filing that states it, Jodi Devlin directly owned 97,364 shares of TriSalus Life Sciences, Inc. (TLSI). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jodi Devlin bought or sold stock recently?
- The most recent open-market sale was on March 16, 2026: sold 3,207 shares of TriSalus Life Sciences, Inc. (TLSI) for $13.2K at an average of $4.11.
- How do I get alerts when Jodi Devlin files?
- Follow Jodi Devlin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jodi Devlin (SEC CIK 0001992151). Totals count each trade once, skipping amendments whose original is on file, from Sep 1, 2023 on. View on SEC EDGAR